Please select your location and reference genome:
Select your region

Please select your preferred region, either the global region for international content or the United States region.

Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP

We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine. 

Read more

Congenica selected for final phase of Instand-NGS4P

Congenica has been selected for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology.

Read more
news carousel brand shapes only 960 x 270

Webinar: From Research to Transforming Patients' Lives

Congenica founders celebrate a decade of innovation

Read more
news carousel brand shapes only 960 x 270

Professor Matthew Hurles discusses the Deciphering Developmental Disorders study

Read more

Congenica announces Early Access Program for its novel Precision Oncology Solution

Read more

Transforming Cancer Care at ESHG 2023

Satellite Symposium from ESHG 2023 featuring Andrew Biankin and Philip Beer who discuss what's needed to transform cancer care today

Read more

Driving Precision Medicine

Who we are

We are a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale.


We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide.


Driving Precision Medicine

To find out more about Congenica, please download our corporate brochure.

Our customers and partners

We are the exclusive Clinical Decision Support Partner for the National Health Service (NHS) Genomic Medicine Service and have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.

National program logos
Strategic Accounts logos
Partnership logos

Our Technology

Congenica was founded on pioneering work at the Wellcome Sanger Institute and the UK NHS. Our products combine state-of-the-art technology, market-leading automation and Artificial Intelligence to enable our uniquely differentiated platform to be employed in all areas of human disease where genomic information is key to unlock actionable insights. 


Automated platform

Full automation with powerful APIs and ML to reduce burden on specialist staff, maximise case throughput, accelerate decision-making and streamline reporting

icon quality light blue-1

CE-IVD approved software

Certified, accurate and secure analysis platform to support clinical decisions with the highest degree of confidence in the clinical outcome

icon flexibility light blue

Ultimate flexibility

From gene panels to whole genomes, SaaS or on premise, we offer ultimate flexibility to support all customer needs

icon integration pale blue

Easy-to-integrate solution

APIs designed to be compatible with existing workflow solutions, LIMS systems and EHRs for optimised operational efficiency


Our Products and Services

Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Our platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care.


At Congenica, we understand how to transform complex genetic data into actionable insights to drive precision medicine at scale

Rob Denison CEO Congenica